Cerebrolysin in Early Stroke Rehabilitation - Tertiary Study

NARecruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

June 13, 2025

Primary Completion Date

July 15, 2027

Study Completion Date

October 15, 2027

Conditions
Ischemic Stroke, AcuteRehabilitation OutcomeCerebrolysin
Interventions
DRUG

Cerebrolysin treatment

The patients will receive Cerebrolysin treatment, 10 days consecutively, 30 ml/day, intravenous infusion diluted up to 100 ml of 0.9% saline in 15 minutes.

OTHER

Standard treatment (including neurorehabilitation) of acute ischemic stroke

"Standard treatment entails acute ischemic stroke reperfusion treatment according to international guidelines and local policies, instituting secondary preventive treatment, a proper management of stroke risk factors and neurorehabilitation according to patient's needs: locomotor physiotherapy, occupation therapy, speech therapy, and neuropsychological assessment."

Trial Locations (1)

1000

RECRUITING

UMC Ljubljana - Department of Vascular Neurology and Intensive Neurological Therapy (KOVNINT), Ljubljana

All Listed Sponsors
lead

University Medical Centre Ljubljana

OTHER

NCT07043686 - Cerebrolysin in Early Stroke Rehabilitation - Tertiary Study | Biotech Hunter | Biotech Hunter